+23.5%
GSK vs ARWR
+201.3%
-177.9%
-18.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | ARWR | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.2% | -2.9% | +3.1% | +0.4% |
| 7D | -3.6% | -3.2% | -0.4% | -3.4% |
| 30D | -5.9% | -6.5% | +0.5% | -5.5% |
| 3M | -4.3% | +12.7% | -16.9% | -5.3% |
| 6M | -10.8% | +36.2% | -47.0% | -13.4% |
| YTD | +1.8% | +24.5% | -22.7% | -1.1% |
| 1Y | +23.5% | +198.0% | -174.5% | +8.4% |
| All | +23.5% | +201.3% | -177.9% | +8.4% |
Cumulative growth
Daily Returns
Daily percentage return beside ARWR.
Daily Out/Under-Performance
Portfolio return minus ARWR return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ARWR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded ARWR wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling